Related Experiment Video

Updated: Aug 21, 2026

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
06:36

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds

Published on: September 8, 2021

Staphylococcus aureus Colonization and Nosocomial Infections: Implications for Prevention

Philip M Polgreen1, Loreen A Herwaldt

  • 1University of Iowa Carver College of Medicine, 200 Hawkins Drive, Iowa City, IA 52242, USA. loreen-herwaldt@uiowa.edu.

Current Infectious Disease Reports
|November 13, 2004
PubMed

Insights

Staphylococcus aureus colonization increases infection risk. While intranasal mupirocin can eradicate colonization, widespread use has led to resistance, necessitating new strategies to prevent Staphylococcus aureus infections.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Antimicrobial Resistance

Background:

  • Staphylococcus aureus colonization is a significant risk factor for invasive infections.
  • Intranasal mupirocin has been effective in eradicating S. aureus colonization and preventing nosocomial infections in certain patient groups.
  • Widespread use of mupirocin has resulted in the emergence of S. aureus resistance.

Purpose of the Study:

  • To highlight the challenge posed by mupirocin resistance in Staphylococcus aureus.
  • To emphasize the need for novel strategies to combat S. aureus infections.
  • To underscore the importance of addressing antimicrobial resistance in clinical settings.

Main Methods:

  • Literature review on Staphylococcus aureus colonization and mupirocin efficacy.
  • Analysis of trends in mupirocin resistance.
  • Identification of gaps in current S. aureus infection prevention strategies.

Main Results:

  • Mupirocin resistance is an increasing concern in both hospital and community settings.
  • The effectiveness of mupirocin is compromised by emerging resistance.
  • Existing methods for preventing S. aureus infections are becoming less reliable.

Conclusions:

  • New therapeutic strategies and agents are urgently required to effectively decrease the risk of Staphylococcus aureus infections.
  • Addressing antimicrobial resistance is crucial for public health.
  • Continued research into alternative treatments for S. aureus colonization and infection is essential.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...